Current Neuro-Oncology
Volume
28 Number 17
20 June 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 17, 20 June
Main
S, Swampillai A, Lavrador J, Al-Salihi O, Brazil L, Chia K, Manik
V, Chin J, Clarke E, Reis Ferreira M.
Broad-Spectrum
Antibiotics are Associated with worse Survival After Radical
Treatment for Glioblastoma Multiforme: A Multicentre Study.
Clin
Oncol (R
Coll Radiol). 2026 Jun 12;56:104209. doi:
10.1016/j.clon.2026.104209. PMID:
42385468. ˍ
Walke V, S S, Agrawal A, Joshi D, Shrivastava A, Sharma T, Tandon
A.
Angiogenic Factors in Adult Diffuse
Glioma and Their Correlation With Tumor Grade: An Observational
Study.
Cureus.
2026 Jun 13;18(6):e110772. doi:
10.7759/cureus.110772. PMID:
42445651. ˍ
Freeburg
NF, Chafamo D, Konanur Gopikrishna G, Murphy RM, Peng JJ,
Parthasarathy S, Dumont S, Estrada EG, Logun MT, Sun Y, Wang X,
Grover P, Rodriguez JL, Zhang DL, Park K, Fu Y, Ben Hamouda N,
Hernandez-Verdin I, Lamrani L, Hicks KA, Cooper NA, Ekwegbara C,
Bawden EG, Waterfall JJ, Fuentealba J, Alcantara M, Seykora JT,
Prouty SM, Barrett D, Banerjee E, Cox A, Assenmacher CA, Macia C,
Yin M, Carpenter EL, Ming GL, Sautès-Fridman C, Fridman WH,
Tartour E, Wherry EJ, Amigorena S, Fraietta JA, Nasrallah MP, Song
H, Miller TE, Bagley SJ, O'Rourke DM, Binder ZA, Alanio C,
Silverbush D.
The
critical role of the endogenous immune compartment after CAR T
cell therapy in recurrent GBM.
Cell.
2026 Jun 15:S0092-8674(26)00585-4. doi:
10.1016/j.cell.2026.05.026. PMID:
42296961. Trial
registration ID:
NCT05168423.
ˍ
Lee
J, Sim J, Lee YG, Lee GW, Jung HA, Kim KP, Kim TY, Ryu H, Ryu MH,
Ahn MS, Kwon M, Keam B, Bae JM, Kim S, Koo H, Kim SY, Kim JH, Lee
S.
Erlotinib
plus bevacizumab in EGFR-amplified metastatic solid tumors:
results from the KOSMOS I, II study of molecular profiling-guided
therapy in advanced cancers.
Int
J Clin Oncol.
2026 Jun 15. doi:
10.1007/s10147-026-03080-5. PMID:
42298055. Trial
registration ID:
NCT05525858. ˍ
Nguyen
S, Ratnasingam D, Hartman KC.
Lorazepam
for post-operative pediatric cerebellar mutism syndrome: A case
report.
J
Pediatr Rehabil Med.
2026 Jun 16:18758894261461379. doi:
10.1177/18758894261461379. PMID:
42300286. ˍ
Santos JN, Batista FS, Sanches F, Miranda A, Santiago M,
Castanheira B, Gonçalves-Nobre JG, Lima P, Nogueira FS,
Brito J.
Exceptional Long-Term Disease
Stability Under Nivolumab in Recurrent High-Grade Glioma: A Case
Report.
Cureus.
2026 Jun 16;18(6):e110942. doi:
10.7759/cureus.110942. PMID:
42465174. ˍ
Anvari
K, Javadinia SA, Fazilatpanah D, Esmaily H, Aledavood SA,
Shahidsales S, Ganjeifar B, Dayani M, Rabiei P.
Comparing
the Recurrence Patterns of Reduced-Margins vs. RTOG-Protocol in
Adjuvant Chemoradiation of High-Grade Gliomas: A Multicenter,
Open-Label, Randomized Controlled Trial.
Asian
Pac J Cancer Prev.
2026 Jun 18;27(6):2005-2013. doi:
10.31557/APJCP.2026.27.6.2005. PMID:
42345146. Trial
registration ID:
IRCT20210215050367N1. ˍ
Dimova
L, Stritzelberger J, Dimov D, Ort J, Hamou HA, Clusmann H, Schnell
O, Hamer H, Putz F, Corradini S, Singer L, Dörfler A,
Ricklefs F, Drexler R, Simon M, Heiland DH, Delev D.
Tumor-associated
epilepsy at diagnosis in glioblastoma patients reveals an
inflammatory molecular signature and is associated with better
overall survival.
Neuro
Oncol.
2026 Jun 19:noag134. doi:
10.1093/neuonc/noag134. PMID:
42320046˰ ˍ